Tài liệu nghiên cứu Y học

European Journal of Pharmaceutics and Biopharmaceutics

CiteScore: 5.25 ℹ
Impact Factor: 4.708 ℹ
5-Year Impact Factor: 5.111 ℹ
Source Normalized Impact per Paper (SNIP): 1.503 ℹ
SCImago Journal Rank (SJR): 1.326 ℹ

Explore journal content


The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.

Topics covered include for example:

  • Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
  • Aspects of manufacturing process design
  • Biomedical aspects of drug product design
  • Strategies and formulations for controlled drug transport across biological barriers
  • Physicochemical aspects of drug product development
  • Novel excipients for drug product design
  • Drug delivery and controlled release systems for systemic and local applications
  • Nanomaterials for therapeutic and diagnostic purposes
  • Advanced therapy medicinal products
  • Medical devices supporting a distinct pharmacological effect

"The Rules of 3"

The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:
1. The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance.
2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.
3. The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.